Methylfolate, the active form of folate, is directly utilized by the body, bypassing enzymatic conversion. This is especially beneficial for individuals with MTHFR gene mutations, improving overall folate status.
Methylfolate, the active form of folate, bypasses the enzymatic conversion process required for folic acid utilization. This direct availability is particularly advantageous for individuals with MTHFR gene mutations, who often experience impaired folate conversion. Consequently, methylfolate supplementation supports healthy cell growth and function, DNA synthesis, and neurotransmitter production, leading to improved overall folate status.